Log in

ASX:SOMSomnomed Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/13/2020)
Today's Range
Now: A$1.08
50-Day Range
MA: A$1.12
52-Week Range
Now: A$1.08
Volume95,124 shs
Average VolumeN/A
Market Capitalization$79.01 million
P/E RatioN/A
Dividend YieldN/A
SomnoMed Limited, together with its subsidiaries, produces and sells devices for the oral treatment of sleep related disorders in Australia and internationally. Its products include SomnoDent, an oral appliance for obstructive sleep apnea; and SomnoBrux, a mouthguard for the treatment of teeth grinding damage, as well as SomTabs for cleaning its devices. The company was founded in 2004 and is based in Crows Nest, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.00 out of 5 stars

Industry, Sector and Symbol

Industry Medical Devices
Phone61 2 9467 0400



Sales & Book Value

Annual Sales$63.33 million
Cash FlowA$0.14 per share
Book ValueA$0.32 per share



Market Cap$79.01 million
Next Earnings DateN/A
OptionableNot Optionable

Receive SOM News and Ratings via Email

Sign-up to receive the latest news and ratings for SOM and its competitors with MarketBeat's FREE daily newsletter.

Somnomed (ASX:SOM) Frequently Asked Questions

Has Somnomed been receiving favorable news coverage?

News headlines about SOM stock have been trending somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Somnomed earned a daily sentiment score of -1.1 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutSomnomed.

Who are some of Somnomed's key competitors?

Who are Somnomed's key executives?

Somnomed's management team includes the following people:
  • Mr. Neil Verdal-Austin, Chief Exec. Officer
  • Mr. Hervé Fiévet, Chief Financial Officer
  • Mr. Martin Weiland, Exec. VP of Sales and Marketing - Europe
  • Mr. Kien T. Nguyen, Exec. Pres of North America
  • Dr. Jagdeep Bijwadia, Chief Medical Officer

What is Somnomed's stock symbol?

Somnomed trades on the ASX under the ticker symbol "SOM."

What is Somnomed's stock price today?

One share of SOM stock can currently be purchased for approximately A$1.08.

How big of a company is Somnomed?

Somnomed has a market capitalization of $79.01 million and generates $63.33 million in revenue each year.

What is Somnomed's official website?

The official website for Somnomed is somnomed.com.

How can I contact Somnomed?

The company can be reached via phone at 61 2 9467 0400.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.